LEAP2 as a therapeutic target in obesity and cardiometabolic disorders.
Saved in:
| Title: | LEAP2 as a therapeutic target in obesity and cardiometabolic disorders. |
|---|---|
| Authors: | Holm SK; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Johansen VBI; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Clemmensen C; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. chc@sund.ku.dk. |
| Source: | Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2026 Jun; Vol. 27 (3), pp. 687-704. Date of Electronic Publication: 2025 Nov 24. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-2606 |
|---|---|
| DOI: | 10.1007/s11154-025-10007-4 |
